POPULARITY
Categories
42 episodes with Health data
86 episodes with Health data
68 episodes with Health data
62 episodes with Health data
74 episodes with Health data
52 episodes with Health data
18 episodes with Health data
24 episodes with Health data
14 episodes with Health data
22 episodes with Health data
9 episodes with Health data
6 episodes with Health data
5 episodes with Health data
8 episodes with Health data
12 episodes with Health data
4 episodes with Health data
5 episodes with Health data
6 episodes with Health data
5 episodes with Health data
11 episodes with Health data
3 episodes with Health data
3 episodes with Health data
6 episodes with Health data
2 episodes with Health data
4 episodes with Health data
4 episodes with Health data
4 episodes with Health data
3 episodes with Health data
2 episodes with Health data
4 episodes with Health data
9 episodes with Health data
2 episodes with Health data
2 episodes with Health data
3 episodes with Health data
2 episodes with Health data
4 episodes with Health data
Vasanta Pundarika built her career inside healthcare investment banking before launching Lotuspring, an advisory firm focused on women's health and behavioral health. She spent nearly 20 years advising healthcare systems, treatment providers, and growth stage companies on mergers, financing, and operational strategy while watching the industry repeatedly misunderstand the people it claimed to serve.The conversation starts unexpectedly with anthropology, bread, and language. Vasanta explains how she spent years changing the pronunciation of her own name to make other people comfortable before eventually reclaiming it. That thread opens into a much larger discussion about adaptation, identity, and what institutions quietly train people to tolerate.From there, the discussion moves into behavioral health, women delaying care, and the invisible labor that healthcare business models routinely ignore. During COVID, Vasanta noticed men's behavioral health units refilled faster than women's units. The reason had nothing to do with demand. Women were still home managing caregiving responsibilities, children, aging parents, and households while their own mental health collapsed in the background.The episode examines what happens when healthcare companies become “snazzy big brands” before building real clinical substance underneath. Vasanta describes the tension between mission and margin inside healthcare startups, private equity backed care models, and behavioral health expansion. The conversation pushes on who benefits when healthcare scales aggressively, who absorbs the operational pressure, and how patient trust erodes long before executives notice it on a dashboard.They also discuss patient advocacy culture, anthropology as systems analysis, healthcare capitalism, prior authorization, investor language, and why some clinically excellent companies never survive long enough to scale.RELATED LINKSVasanta PundarikaLotuspringWomen's Health HorizonsSakhi for South Asian SurvivorsNACDPrinceton University Anthropology DepartmentFEEDBACKLike this episode? Rate and review Out of Patients on your favorite podcast platform. For guest suggestions or sponsorship email podcasts@matthewzachary.comSee Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.
Send us Fan MailAmerican healthcare spends an estimated $110 per member per month just to administer itself, before a single service is ever delivered. Most of that cost exists because health data still cannot move freely between the systems that need it.Michael Meucci, CEO of Arcadia, joins host John Driscoll to discuss why two decades of interoperability policy have failed to solve the data fragmentation problem facing health systems and payers, and why liberating that data and redirecting the administrative spend it currently requires could be the single biggest lever available for improving both the cost and quality of American healthcare.
The way U.S. aid is distributed around the world has changed significantly since the beginning of President Trump's second term. Reporting by ProPublica shows that a series of new agreements between the United States and various African countries is tying funding to access to those countries' health data. So what kind of data is accessible and who stands to benefit? Also: setting the backdrop to Fed Chair Kevin Warsh's first Congressional testimony.Every story has an economic angle. Want some in your inbox? Subscribe to our daily or weekly newsletter.Marketplace Morning Report is more than a radio show. Check out our original reporting and financial literacy content at marketplace.org — and consider making an investment in our future.
The way U.S. aid is distributed around the world has changed significantly since the beginning of President Trump's second term. Reporting by ProPublica shows that a series of new agreements between the United States and various African countries is tying funding to access to those countries' health data. So what kind of data is accessible and who stands to benefit? Also: setting the backdrop to Fed Chair Kevin Warsh's first Congressional testimony.Every story has an economic angle. Want some in your inbox? Subscribe to our daily or weekly newsletter.Marketplace Morning Report is more than a radio show. Check out our original reporting and financial literacy content at marketplace.org — and consider making an investment in our future.
Brad Power spent years advising major corporations on systems design, process engineering, and decision making before lymphoma shoved him into the patient side of American healthcare. Instead of accepting the experience at face value, he started reverse engineering the machinery around cancer itself. Brad is the founder of Cancer Patient Lab and Open Cancer AI, two projects built around a blunt reality most patients discover too late: the healthcare system rewards people who know how to navigate it. Everyone else risks getting steamrolled by information asymmetry, insurance barriers, administrative friction, and institutional incentives designed around efficiency instead of human survival.The conversation starts with Harvard Business Review and Tumblr blogs before moving directly into the darker architecture underneath modern cancer care. Power explains how hospitals optimize for throughput, how insurance companies reward operational consistency over personalized medicine, and why many patients quietly end up needing a crash course in oncology, reimbursement policy, and behavioral psychology while fighting for their lives.The discussion digs into CAR-T therapy, functional testing, AI assisted decision support, and the growing collision between personalized medicine and standardized care pathways. Power argues that engaged patients often get better outcomes because they learn how to push for off guideline treatments, contest denials, and ask smarter questions. The counterpoint lands hard: patients should never have needed to become experts in the first place.The episode also explores the cultural consequences of AI entering cancer care. OpenAI advertising, data privacy, trust erosion, pharmaceutical influence, and “agentic AI” all collide inside a healthcare economy already drowning in distrust. Power sees artificial intelligence as a force multiplier for patient literacy and access. The larger system still decides who gets approved, who gets delayed, and who gets left behind.By the end, the conversation lands exactly where modern healthcare keeps forcing people to land: survival increasingly depends on learning how the machine works before the machine works on you.RELATED LINKSBrad PowerCancer Patient LabOpen Cancer AIHarvard Business ReviewResearch to the PeopleCAR T Cell TherapyFEEDBACKLike this episode? Rate and review Out of Patients on your favorite podcast platform. For guest suggestions or sponsorship email podcasts@matthewzachary.comSee Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.
By the time the paper hit version 71, Dr. Nirosha Murugan had already done the hard part. The data were real. The experiment had worked. A team of researchers had used a wearable bioreactor to trigger limb regeneration in frogs, a result with obvious implications for regenerative medicine. But the science still wasn't getting over the line. The problem wasn't the work. It was the translation.On this episode of Standard Deviation, host Oliver Bogler talks with Dr. Nirosha Murugan, a biophysicist and Tier II Canada Research Chair in Tissue Biophysics at Wilfrid Laurier University, about what happens when a scientist working at the edges of quantum biology, bioelectricity, and tissue regeneration runs headfirst into the unwritten rules of academic publishing. Murugan's research asks biologists to think beyond molecules and chemistry alone, and to consider the physical signals, electromagnetic fields, and invisible forces that shape development and healing. It is ambitious science. It is also exactly the kind of work that can make gatekeepers nervous.Bogler follows Murugan through the less glamorous part of discovery: the hidden curriculum of getting a paper published, securing scientific credibility, and learning that data do not simply “speak for themselves.” Murugan describes how jargon buried the pitch of her own work, how a lack of editorial support left her at a disadvantage, and how the JEDI program at the Life Science Editors Foundation paired her with a former journal editor who taught her how to structure a manuscript, write a cover letter, and survive peer review.The result was publication in Science Advances, but the larger story is about power. Who gets taught the rules of biomedical research. Who has access to grant writers, editors, and institutional polish. Who is left to brute-force their way through the maze. And how one scientist, having finally found the map, now makes sure her own trainees do not have to learn it the hard way.RELATED LINKSDr. Nirosha MuruganWilfrid Laurier UniversityLife Science Editors FoundationJEDI ProgramScience Advances paper on limb regenerationFEEDBACKLike this episode? Rate and review Out of Patients on your favorite podcast platform. For guest suggestions or sponsorship email podcasts@matthewzachary.comSee Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.
Dr. Jess Peatross trained in conventional medicine and worked as a hospitalist before she started questioning why so many chronically ill patients kept getting worse inside the healthcare system she trusted. Her perspective carries weight because she spent years following every protocol exactly as taught before walking away from hospital medicine entirely.Raised in Huntington, West Virginia during the opioid crisis, she entered medicine believing the system existed to heal people. Instead, she found hospitals driven by billing codes, liability management, and pharmaceutical dependence while patients with chronic illness, autoimmune disease, mold exposure, and chronic pain cycled endlessly through appointments and prescriptions.Dr. Peatross explains what pushed her toward functional medicine, cannabis therapy, and prevention focused care after watching patients improve only after leaving conventional treatment pipelines behind. The conversation tackles physician burnout, chronic illness stigma, healthcare incentives, and the growing collapse of trust between patients and institutions.The discussion also moves into supplements, environmental toxins, ultra processed food, and the uncomfortable economics behind keeping people permanently sick but continuously billable. Dr. Peatross describes the professional backlash that comes with challenging medical orthodoxy while Matthew connects her experience to the broader erosion of public trust across American healthcare.Together they unpack what happens when patients stop believing the system can help them and start searching elsewhere for answers.RELATED LINKSDr. Jess PeatrossInstagramMarshall UniversityBrave New WeedFEEDBACKLike this episode? Rate and review Out of Patients on your favorite podcast platform. For guest suggestions or sponsorship email podcasts@matthewzachary.comSee Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.
Futura Medical PLC (AIM:FUM, OTC:FAMDF, FRA:GYX) CEO Alex Duggan and head of R&D Ken James joined Proactive's Stephen Gunnion to discuss a new US commercial partnership for Eroxon and encouraging clinical data for women's sexual health candidate WSD4000. Duggan explained that Market Performance Group brings extensive consumer healthcare experience and will handle commercial execution, advertising, distribution and customer operations in the US. The arrangement shifts Futura away from a traditional licensing model, giving it greater control over brand strategy, promotional investment and product supply while leveraging MPG's market expertise. James outlined results from two WSD4000 studies — a 228-woman home user study showing high levels of reported improvement in sexual function, and a placebo-controlled study demonstrating statistically significant results — providing confidence ahead of the planned Phase 3 pivotal trial. Regulatory submissions are expected after trial completion, with a potential launch targeted for early 2028 in both the US and Europe, subject to funding. "These results really are incredibly positive," Duggan said. "It gives us a lot of confidence, both in moving towards the phase three pivotal trial, which is now significantly de-risked, but also an indication as to the likely market success." Visit the Proactive YouTube channel for more interviews with leading companies and market insights. If you enjoyed this video, please give it a like, subscribe to the channel and enable notifications so you never miss future content. #FuturaMedical #Eroxon #WSD4000 #WomensHealth #SexualHealth #ConsumerHealthcare #Biotech #HealthcareInnovation #ClinicalTrials #FDA #MedicalDevices #Investing #Stocks #SmallCaps #Proactive
Farla Efros is a senior retail executive and former CEO who built and sold companies before facing her own breast cancer diagnosis. She brings that same operational mindset into a healthcare system that expects patients to manage complexity while they are at their most vulnerable.She was on a client call in Spain when the diagnosis came through. A clear mammogram had missed it. An MRI caught it. Within hours, she was ordering binders, building a plan, and structuring her treatment like a turnaround strategy. Every appointment became a meeting. Every doctor faced an agenda with dozens of questions. She paid out of pocket for PET scans that were denied and hired a third party firm to validate her treatment path when her own doctors resisted outside input. The conversation tracks what happens when a high-functioning executive enters a system built on delay, denial, and fragmentation. Efros describes negotiating for tests, managing physician relationships, and assembling an “executive board” of advisors across conventional and alternative care. She calls the experience “the worst client I ever had,” exposing how administrative burden shifts onto patients and families.The tension sits between what worked for her and what is inaccessible to most. Her approach requires confidence, time, and fluency in navigating power. The system rewards that behavior while quietly failing patients who cannot replicate it. Insurance coverage still left her paying out of pocket. Doctors pushed standard protocols over precision medicine. Survivorship offered little support once treatment ended.This episode examines how cancer care operates as a series of incentives rather than a coordinated system, and why patients are forced to become operators just to get through it.RELATED LINKSFarla EfrosFarla Efros on LinkedInF*ck CancerF*ck Cancer on AmazonAccentureCTOAMPULL QUOTES“I treated cancer like the worst client I ever had.”“They wouldn't approve the test, so I paid for it myself.”“Every appointment was a negotiation.”FEEDBACKLike this episode? Rate and review Out of Patients on your favorite podcast platform. For guest suggestions or sponsorship email podcasts@matthewzachary.comSee Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.
In 2020, Emily Mendenhall drove from Washington, DC to Okoboji, Iowa, a town of 800 that swells to 200,000 every summer, and walked into a pandemic that looked nothing like the one dominating national headlines. Inside gas stations and bars, masks marked you as an outsider. In one stop, a man told her family they would not be served if they kept theirs on. Her 6 year old daughter cried, confused. Mendenhall, a medical anthropologist at Georgetown University, did what she always does. She started asking questions. Over months, she interviewed neighbors, former classmates, and local officials, including her own brother in law who helped lead the local COVID response. The result became Unmasked, a case study in how community identity, economics, and politics shaped public health decisions in real time. That work led directly into her latest book, Invisible Illness: A History, from Hysteria to Long COVID, where she tracks a much older problem. Patients with chronic illness, especially women, often fail to meet medicine's demand for proof. Without a clear diagnosis, they lose access to care, insurance coverage, and legitimacy. Mendenhall argues that long COVID did not create this failure. It exposed it.This conversation centers on how healthcare systems reward certainty and punish complexity. Long COVID clinics send patients to 17 specialists without resolution. Insurance structures require diagnoses that many conditions cannot provide. Medical training still struggles to integrate trauma, mental health, and chronic disease into a coherent model of care.Mendenhall brings lived experience into the conversation. After COVID, she dealt with months of fatigue and escalating anxiety that altered her baseline health. She does not claim the label of long COVID, but she understands how quickly the system becomes harder to navigate once symptoms stop fitting clean categories. The stakes are not theoretical. In the United States, access to healthcare, disability benefits, and treatment still depends on whether a condition can be measured, coded, and reimbursed. For millions living with invisible illness, the burden of proof becomes the illness itself.RELATED LINKSEmily MendenhallInvisible Illness: A History, from Hysteria to Long COVIDScience PoliticsGeorgetown UniversityFEEDBACKLike this episode? Rate and review Out of Patients on your favorite podcast platform. For guest suggestions or sponsorship email podcasts@matthewzachary.comSee Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.
In this candid, no-filters episode of Old Man Strength, hosts Tim Johnson and Chris Shipley sit down with Ross Eveland, Democratic candidate for Story County Supervisor, for a real conversation about local government, why he's running, and the issues that actually affect everyday Iowans.Ross shares his rural roots growing up on a century farm near Oskaloosa, his time at Iowa State, and the path that led him through substitute teaching, Instacart/Walmart deliveries, and umpiring baseball and football (including college games). He explains what county supervisors actually do — managing budgets, secondary roads, planning & zoning, and property taxes — and why he believes competitive races and representation from outside Ames are essential, especially after recent district changes.The conversation dives deep into the issues Ross is prioritizing:Expanding mental health services and first-responder training in rural Story CountyImproving roads, bridges, and infrastructureTax rate transparency and fiscal responsibilityStrong opposition to large data centers and their impact on water, electricity rates, farmland, and long-term local jobsCutting through partisan noise to actually listen to constituentsRoss also opens up about the importance of checking in on friends and family for mental health, the critical shortage of sports officials, and why everyday people should consider running for local office to give voters real choices on the ballot.Recorded live from the AKC Andrew Downs Studios and powered by Revelton Distilling Company. Sponsored by Iowa Beef Steakhouse, Jenny Farrell with RE/MAX Concepts, and Styled by JJ Boutique.If you care about local government, rural Iowa issues, or just want an honest conversation about what county supervisors actually do, this one's worth your time.Subscribe to Old Man Strength for more unfiltered talk from Three Beards Media. New episodes weekly.
At 25, Jace Yawnick was building a career in health and wellness sales, chasing growth, status, and the usual young adult fantasy of getting somewhere fast. Then his body stopped cooperating. Fatigue turned into chemotherapy. The diagnosis was primary mediastinal B cell non Hodgkin lymphoma, and the rest of his life split into before and after. Now in remission, he talks about cancer the way people actually live it, not the way nonprofits package it. He gets into survivorship, mental health, young adult isolation, and the deadening absurdity of prior authorization. One of the sharpest parts of the conversation lands on a simple American insult disguised as policy: treatment innovation means very little when insurance can still deny the scan, the drug, or the next step. Jace has seen that firsthand, including during routine monitoring after active treatment. This episode tracks what happens when a young cancer patient becomes a public voice and refuses to play mascot. It covers oncology, insurance, remission, advocacy, and the long mental hangover that follows survival. It also names the part too many institutions dodge: the system works great right up until it doesn't, and when it fails, patients get handed the bill, the panic, and a camera if they want anyone to care. RELATED LINKSJace Beats CancerJace Yawnick on LinkedImConquer Cancer ArticleCURE Today ArticlePyure BrandsFEEDBACKLike this episode? Rate and review Out of Patients on your favorite podcast platform. For guest suggestions or sponsorship email podcasts@matthewzachary.comSee Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.
What if many of the answers to better health have nothing to do with another prescription? In this thought-provoking episode, Drs. May and Tim Hindmarsh sit down with Emma Tekstra, actuary, global health consultant, and author of How to Be a Healthy Human, to challenge conventional assumptions about modern healthcare. Drawing on decades of experience analyzing health data and employee health programs, Emma shares why she believes true wellness requires a broader perspective than symptom management alone. The conversation explores personal responsibility, critical thinking, chronic disease trends, the business side of healthcare, and the often-overlooked roles of lifestyle, community, purpose, and spiritual wellbeing. Whether you agree with every point or simply enjoy examining healthcare through a different lens, this episode offers plenty to consider. In This Episode Emma's journey from actuary to health advocate Why she began questioning conventional approaches to chronic illness The difference between healthcare and true wellness How lifestyle choices influence long-term health outcomes The role of critical thinking in healthcare decisions Why social connection and purpose matter for longevity Data-driven perspectives on modern health trends The concept of taking ownership of your health journey Lessons from researching health and longevity around the world What inspired her book, How to Be a Healthy Human About Emma Tekstra Emma Tekstra is an actuary, global health consultant, educator, and author of How to Be a Healthy Human: What Your Doctor Doesn't Know About Health and Longevity. A Fellow of the Institute and Faculty of Actuaries, she spent more than two decades advising major employers on healthcare and benefits strategy before focusing her work on helping individuals and organizations better understand what drives human health and wellbeing. Resources & Links Emma Tekstra: https://www.emmatekstra.com Emma's Substack: https://emmatekstra.substack.com How to Be a Healthy Human: https://www.amazon.com/dp/1510779507 Listen and Subscribe Website: https://www.bsfreemd.com Follow BS Free MD on your favorite podcast platform and join Drs. May and Tim Hindmarsh each week as they challenge assumptions, explore new ideas, and have conversations that go beyond the headlines. Disclaimer The content of this podcast is for educational and informational purposes only and should not be considered medical advice. Listening to this podcast does not establish a physician-patient relationship. Always consult your own healthcare professional regarding medical decisions.
At 20 years old, newly arrived from Puerto Rico and trying to build a future in science, Benjamin Suarez Jimenez found himself sitting in front of two senior faculty members accused of plagiarism. He knew the material. He had done the work. His mistake came from failing to cite class notes during an exam because nobody had told him that was expected. In a matter of minutes, he watched what felt like his entire career flash before him.On this episode of Standard Deviation, host Oliver Bogler examines the hidden architecture of academic science through the experiences of Dr. Benjamin Suarez Jimenez, Assistant Professor at the University of Rochester and a neuroscientist studying PTSD, anxiety, trauma, and spatial cognition through virtual reality and video game environments.Benjamin traces his path from Puerto Rico to the mainland United States, through the NIH, Columbia University, and eventually to leading his own laboratory. Along the way, he encountered a series of barriers that had little to do with scientific ability and everything to do with access to unwritten rules. From academic gatekeeping to grant writing expectations, he learned that success in biomedical research often depends on knowledge that never appears in a textbook.Oliver explores how those invisible obstacles shape careers, influence research funding, and determine who gains access to opportunity. The conversation also examines the Justice, Equity, Diversity, and Inclusion Program at the Life Science Editors Foundation, which pairs scientists from underrepresented backgrounds with experienced scientific editors. Through that mentorship, Benjamin transformed a critical grant proposal into a successful pilot award that helped launch an NIH R01 application.The discussion extends beyond one scientist's experience. Benjamin describes helping a former mentee navigate dissertation roadblocks that threatened her graduation, illustrating how institutional bureaucracy can delay careers and discourage talented researchers. Together, they explore the hidden administrative burden, cultural barriers, and bias that many scientists carry alongside their research, and what happens when someone who receives support turns around and opens the door for others.RELATED LINKSLife Science Editors FoundationBenjamin Suarez Jimenez LabDr. Benjamin Suarez JimenezBenjamin Suarez JimenezFEEDBACKLike this episode? Rate and review Out of Patients on your favorite podcast platform. For guest suggestions or sponsorship email podcasts@matthewzachary.comSee Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.
Dr. Sarah Matt trained as a burn surgeon, working in a field where patients arrive with catastrophic injuries and survival depends on speed, skill, and resources. She left the bedside after confronting a limit that medicine does not like to admit. One physician can only see so many people in a day. The system surrounding those patients decides the rest. She moved into health technology, held leadership roles in startups, and built global infrastructure at Oracle to scale care across populations. Then she watched billions of dollars in digital health and AI initiatives stall out when they hit real clinical environments.This episode follows that pivot from surgeon to strategist and back into direct patient care in rural New York, where she now treats uninsured patients, migrant workers, and communities pushed to the margins. The conversation centers on a persistent failure across healthcare systems. Products get built for regulators, executives, and investors instead of the people who use them. The result shows up in failed adoption, broken workflows, prior authorization delays, and rising physician burnout.The discussion cuts through health policy language and lands on lived consequence. The system rewards speed over usability, scale over trust, and compliance over care. Patients absorb the fallout. Physicians carry the liability. The incentives remain intact.RELATED LINKSDr. Sarah MattThe Borderless Healthcare RevolutionThe Clinical RealistJessica FedererSovatoFEEDBACKLike this episode? Rate and review Out of Patients on your favorite podcast platform. For guest suggestions or sponsorship email podcasts@matthewzachary.comSee Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.
In this episode of The International Risk Podcast, Dominic Bowen speaks with Phil Booth, coordinator of medConfidential and a long-standing campaigner on medical confidentiality, patient consent and data governance, about what Palantir's growing role in the NHS reveals about public trust, private technology companies and the data infrastructure increasingly underpinning the modern state. The conversation examines the NHS Federated Data Platform, the use of Palantir Foundry and the wider risks that arise when critical public infrastructure becomes dependent on private technology companies. Phil argues that the central issue is not only whether the software works, but who controls it, how easily it can be scrutinised or replaced, and whether patients have any meaningful choice over how their health data is used. Dominic and Phil discuss the limits of pseudonymisation, weaknesses in current opt-out arrangements, the commercial value created around NHS workflows and data systems, and the danger of long-term vendor lock-in. Phil reflects on earlier disputes surrounding care.data and the extraction of GP records, arguing that successive governments have repeatedly failed to treat public consent as a necessary condition of legitimate health-data use. They also explore how Palantir's work with military, intelligence and policing organisations can create ethical and strategic tensions when the same company becomes deeply embedded in healthcare systems. The International Risk Podcast brings you conversations with global experts, frontline practitioners, and senior decision-makers who are shaping how we understand and respond to international risk. From geopolitical instability and organised crime to cybersecurity threats and hybrid warfare, each episode explores the forces transforming our world and what smart leaders must do to navigate them. Whether you're a board member, policymaker, or risk professional, The International Risk Podcast delivers actionable insights, sharp analysis, and real-world stories that matter. Dominic Bowen is the host of The International Risk Podcast and Europe's leading expert on international risk and crisis management. As Head of Strategic Advisory and Partner at one of Europe's leading risk management consulting firms, Dominic advises CEOs, boards, and senior executives across the continent on how to prepare for uncertainty and act with intent. He has spent decades working in war zones, advising multinational companies, and supporting Europe's business leaders. Dominic is the go-to business advisor for leaders navigating risk, crisis, and strategy; trusted for his clarity, calmness under pressure, and ability to turn volatility into competitive advantage. Dominic equips today's business leaders with the insight and confidence to lead through disruption and deliver sustained strategic advantage. Subscribe for all our updates!Tell us what you liked!
Health data affects artificial intelligence in important ways. Camille Nebeker, Ed.D., M.S., UC San Diego, explains why ethically sourced data is foundational to building trustworthy, AI-ready health data repositories. Nebeker examines how ethical sourcing applies across the full data lifecycle, including consent, governance, transparency, data quality, privacy, stewardship, and community engagement. She also shows how ideas from supply chain management and value sensitive design help teams identify ethical tensions and improve decision-making. This work helps explain why ethics cannot be added at the end of AI development and points toward more accountable data practices that support public trust and stronger downstream performance. Series: "Exploring Ethics" [Science] [Show ID: 41368]
Health data affects artificial intelligence in important ways. Camille Nebeker, Ed.D., M.S., UC San Diego, explains why ethically sourced data is foundational to building trustworthy, AI-ready health data repositories. Nebeker examines how ethical sourcing applies across the full data lifecycle, including consent, governance, transparency, data quality, privacy, stewardship, and community engagement. She also shows how ideas from supply chain management and value sensitive design help teams identify ethical tensions and improve decision-making. This work helps explain why ethics cannot be added at the end of AI development and points toward more accountable data practices that support public trust and stronger downstream performance. Series: "Exploring Ethics" [Science] [Show ID: 41368]
Health data affects artificial intelligence in important ways. Camille Nebeker, Ed.D., M.S., UC San Diego, explains why ethically sourced data is foundational to building trustworthy, AI-ready health data repositories. Nebeker examines how ethical sourcing applies across the full data lifecycle, including consent, governance, transparency, data quality, privacy, stewardship, and community engagement. She also shows how ideas from supply chain management and value sensitive design help teams identify ethical tensions and improve decision-making. This work helps explain why ethics cannot be added at the end of AI development and points toward more accountable data practices that support public trust and stronger downstream performance. Series: "Exploring Ethics" [Science] [Show ID: 41368]
Health data affects artificial intelligence in important ways. Camille Nebeker, Ed.D., M.S., UC San Diego, explains why ethically sourced data is foundational to building trustworthy, AI-ready health data repositories. Nebeker examines how ethical sourcing applies across the full data lifecycle, including consent, governance, transparency, data quality, privacy, stewardship, and community engagement. She also shows how ideas from supply chain management and value sensitive design help teams identify ethical tensions and improve decision-making. This work helps explain why ethics cannot be added at the end of AI development and points toward more accountable data practices that support public trust and stronger downstream performance. Series: "Exploring Ethics" [Science] [Show ID: 41368]
In the late 1980s, a child exposed to fallout from the Chernobyl disaster lay in a hospital bed while doctors told his family there were no clear answers and no reliable path forward. Decades later, that same child, Yan Leyfman, walks into exam rooms as a hematology oncology fellow, expected to deliver clarity inside a system that still runs on delay, uncertainty, and institutional self preservation.This episode traces the throughline from early life shaped by radiation exposure and hospice level uncertainty to a career inside academic medicine, translational research, and oncology media. Yan built his identity around survival and usefulness, moving from patient to physician while carrying the memory of what it feels like to sit on the other side of the table. He helped launch MedNews Week during the COVID crisis to push back on misinformation and expand access to medical knowledge, stepping into a public role while still in training.The conversation stays grounded in the friction between personal narrative and system reality. Clinical training demands efficiency, hierarchy, and emotional distance. Cancer care demands time, clarity, and human connection. Those forces collide in real patient encounters where prior authorization delays, insurance barriers, and fragmented care pathways shape outcomes as much as any treatment protocol.Yan speaks openly about mentorship, belonging, and the drive to make meaning out of survival. The discussion pushes further into what the healthcare system actually rewards, what it quietly strips away, and how quickly empathy can erode under institutional pressure. The episode also examines the role of medical media, where education, industry influence, and narrative control often blur together.This is a conversation about identity under construction, about what happens when someone who remembers powerlessness steps into a role that carries authority, and about whether that memory can survive long enough to change anything.RELATED LINKSYan Leyfman on LinkedInYan Leyfman on InstagramSurviving ChernobylFEEDBACKLike this episode? Rate and review Out of Patients on your favorite podcast platform. For guest suggestions or sponsorship email podcasts@matthewzachary.comSee Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.
The Fifi, Fev & Nick Catch Up – 101.9 Fox FM Melbourne - Fifi Box, Brendan Fevola & Nick Cody
ON TODAY'S FIFI, FEV & NICK: Fifi Has An Oura Ring Update Oura Ring Stats Sardinemaxxing Melbourne, What Happened When You Left Your Kids With Your Partner? Josiah's Confession For Melita Toy Story 5 News The Team Is Loving 'Little Britian' Fev's Dms - Lachie Neale & Macy Gray JB Scared Daisy (part 2) Fev's Surgery Tomorrow Team Nightly Routines Subscribe on LiSTNR: https://play.listnr.com/podcast/fifi-fev-and-nickSee omnystudio.com/listener for privacy information.
In this compelling episode host Myrna Young delves into a groundbreaking discussion with AI and neuroscience visionary, Thoryn Stephens. The conversation explores the intriguing topic of how the future of AI, behavior, and consciousness is reshaping the boundaries of human potential. Thoryn takes us on a journey through the concept of 'mindspan' and its crucial role in understanding cognitive longevity amidst growing concerns over burnout and brain fog.Through an insightful exchange, Thoryn illuminates the power of AI and neuroscience in optimizing brain health, shedding light on strategies to enhance cognitive performance at every stage of life. Highlighting practical habits and tools like brain mapping, neuroplasticity, and lifestyle changes, Stephens reveals how they can stave off cognitive decline and boost aging brains. He emphasizes the significance of community connections, sleep, and direct sunlight as essential elements of a high-performing brain. Tune in to discover how AI interfaces and adaptive protocols designed by Brain One are shaping the future of brain health.Key Takeaways:Mindspan is crucial for maintaining cognitive function and health, aiming for sharper minds rather than merely longer lifespans.Brain health can be improved with microhabits such as proper sleep, direct sunlight, community engagement, and learning new skills.AI is becoming increasingly integrated into understanding and optimizing brain activity through tools like brain mapping and neuroplasticity techniques.Stephens advocates for personalized health protocols driven by adaptive AI to continually tweak and enhance individuals' cognitive health.Thoryn Stevens' Brain One is at the forefront of providing free dementia prevention protocols aimed at public health improvements.Timestamp Summary0:02 AI and Neuroscience Redefining Human Potential4:20 Brain Health, Aging, and Preventative Microhabits15:49 The Importance of Sleep, Sunlight, and Human Behavior in Health20:56 AI and Brain Interfaces Revolutionizing Medical Science25:41 The Intersection of AI, Health Data, and Doctor-Patient Dynamics31:57 Exploring Brain Health and Hormonal Impacts on Women36:06 Exploring Psychedelics for Consciousness and Neuroplasticity40:50 Brain One's Adaptive AI Health Protocols and Free Dementia Initiative45:39 Enhancing Life Quality Through Mindfulness and ConnectionResources:Brain One WebsiteInstagram: BrainBrainFitnessOneInstagram (Thoryn Stevens): RageAreaSponsors of this podcastWith Wegovy at Hers, lose up to 20% or more of your body weight when combined with diet and exercise. Ready to reach your goals? Visit forhers.com/transform to get personalized, affordable care that gets you. See this video on The Transform Your Mind YouTube Channel https://www.youtube.com/@MyhelpsUs/videosTo see a transcripts of this audio as well as links to all the advertisers on the show page https://myhelps.us/Follow Transform Your Mind on Instagram https://www.instagram.com/myrnamyoung/Follow Transform Your mind on Facebookhttps://www.facebook.com/profile.php?id=100063738390977Please leave a rating and review on iTunes https://podcasts.apple.com/us/podcast/transform-your-mind/id1144973094Feedspot Top 100 Mental Health Podcast For sponsored Brand interviews and sponsorship inquires please visit Partner With The Transform Your Mind Podcast | Myrna Young Life Coach
Matthew Zachary is a brain cancer survivor, healthcare advocate, founder of Stupid Cancer and We the Patients, and host of Out of Patients. In April 2026, he returned to the stage at Merkin Hall near Lincoln Center for his first solo public piano concert in almost 22 years while launching his debut book, We the Patients: Understanding, Navigating, and Surviving America's Healthcare Nightmare.What unfolded became far larger than a concert.Over 2 hours, survivors, clinicians, advocates, nonprofit founders, journalists, pharmaceutical sponsors, and healthcare insiders gathered in one room to reflect on 30 years of survivorship, institutional failure, accidental advocacy, and the emotional afterlife of cancer. The evening moved through original piano performances, live chapter readings, and deeply personal conversations about infertility, disability, financial toxicity, insurance denials, grief, burnout, and what happens when patients spend decades navigating systems designed around transactions instead of continuity.Guests including Wendell Potter, Maimah Karmo, Craig Lustig, Shelly Fuld Nasso, Tamika Felder, and others reflected on how the modern cancer advocacy movement emerged largely because patients built parallel systems where healthcare infrastructure failed to meet human needs. The conversation explored how prior authorization, reimbursement incentives, administrative fragmentation, and institutional distrust continue shaping the patient experience across oncology and survivorship.The performance also marked a deeply personal milestone. After brain cancer compromised his left hand at age 21, Zachary spent 6 months rehabilitating both hands to return to public performance for the first time in over 2 decades. The result became part concert, part civic gathering, and part historical record of a generation of survivors who refused to disappear quietly.RELATED LINKSMZLIVE Official WebsiteMZLIVE YouTube VideoFEEDBACKLike this episode? Rate and review Out of Patients on your favorite podcast platform. For guest suggestions or sponsorship email podcasts@matthewzachary.comSee Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.
In Episode 189 of Facts vs Feelings, Ryan Detrick, Chief Market Strategist at Carson Group, and Sonu Varghese, Chief Macro Strategist at Carson Group, break down the disconnect between how people feel about the economy and what the hard data is actually showing. They connect the dots between oil prices, inflation expectations, Treasury yields, and why markets may not be reacting to geopolitical headlines the way many investors expect.It's a real-time look at the K-shaped economy: tighter budgets at the bottom, resilient spending at the top.Ryan and Sonu walk through stretched momentum after an eight-week rally, sector rotation beneath the surface, and another massive earnings season. They also explain why private AI investments are quietly becoming a meaningful contributor to public company profits, something many investors still aren't fully accounting for.Key Takeaways:Oil prices, Treasury yields, and inflation expectations remain tightly connected even when markets appear calm.Consumer behavior is splitting across income levels, reinforcing the idea of a K-shaped economy.Soft data like sentiment surveys continues diverging from hard data like earnings and employment.Earnings, buyback activity, and AI exposure are reshaping market leadership.Market momentum remains strong, but sector leadership underneath the surface keeps rotating.Bond markets may be the biggest force shaping Fed expectations and investor behavior goingJump to:3:06 — Strait Tensions and Oil Prices6:41 — The All-Electric Ferrari Debate8:39 — Consumer Strain Signals13:15 — Consumer Sentiment Hits Record Lows21:37 — Home Water Leaks and Insurance Headaches25:18 — Sector Breadth and Market Leadership33:15 — Momentum Crowding and the Win Streak37:41 —Earnings and Buybacks45:01 — Private AI Valuations Inside Public Earnings48:13 —Health Data and AI Coaching50:44 — Chicago Live Show Details54:00 — Grading Powell and New Fed Risks1:05:12 — Fed Hike Odds and Week AheadConnect with Ryan:• LinkedIn: https://www.linkedin.com/in/ryandetrick/• X: https://x.com/RyanDetrickConnect with Sonu:• LinkedIn: https://www.linkedin.com/in/sonu-varghese-phd/• X: https://x.com/sonusvarghese?lang=enQuestions about the show? We'd love to hear from you! factsvsfeelings@carsongroup.com
In December 1996, a 37 year old pharmaceutical executive sat in a Borders bookstore reading medical textbooks on the floor, trying to understand a disease she had never heard of. Multiple myeloma carried a three year prognosis. Her daughter was 18 months old. Her father had just died of cancer. Within weeks, she pushed her doctors to say the quiet part clearly. This would likely end her life before her child entered kindergarten.Kathy Giusti refused to accept passive survival. She built a plan while the system offered fragments. She interviewed oncologists and fertility specialists at the same time. She pursued IVF to have a second child while preparing for treatment. She stayed employed to keep insurance coverage. Every decision carried financial, medical, and emotional risk.That same urgency exposed a deeper failure. Cancer research moved slowly. Academic centers guarded data. Clinical trials lacked coordination. Patients entered a system that demanded compliance without providing clarity. Giusti responded by building the Multiple Myeloma Research Foundation, not as a support group, but as an operating engine to accelerate drug development, fund research, and force collaboration across institutions.This episode tracks the tension between individual agency and systemic failure. Giusti describes how patients navigate diagnosis, insurance barriers, and fragmented care in real time. She explains how data, genomics, and clinical trials reshape cancer treatment while still leaving patients responsible for decisions they are not trained to make. She addresses disparities in access, the limits of early detection, and the reality that progress in oncology often depends on speed, funding, and alignment of incentives.The conversation moves between lived experience and structural critique. It names the cost of delay, the burden placed on patients to act as their own advocate, and the tradeoffs required to push a system forward that still protects itself first.⸻RELATED LINKSKathy GiustiMultiple Myeloma Research FoundationFatal to FearlessAmerican Society of Hematology⸻FEEDBACKLike this episode? Rate and review Out of Patients on your favorite podcast platform. For guest suggestions or sponsorship email podcasts@matthewzachary.comSee Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.
The Privacy Commissioner has issued a damning report into the hacking of the Manage My Health app - private information of almost 100-thousand New Zealanders was stolen in the breach in December last year. The Commissioner highlighed significant failures by Health New Zealand and Manage My Health, issuing both with compliance notices .. and recommending law changes to strengthen accountability. Health NZ Chief Financial Officer Bevan McKenzie spoke to Ingrid Hipkiss.
At 19, Shlomit woke up unable to speak. The right side of her body went numb. An emergency room sent her home and called it stress. That moment did not end in a diagnosis that changed policy or triggered reform. It sent her into a decade long pursuit of understanding how the brain fails language and how the healthcare system fails patients who cannot advocate for themselves.Shlomit trained as a speech language pathologist and spent years inside acute care hospitals and ICUs, performing endoscopies and treating patients with brain injury, stroke, and dysphagia. She watched medical teams rotate in and out, deliver dense updates, and leave families nodding without comprehension. She stayed behind and translated. Every day, patients told her she was the only one who explained what was happening. That gap is not an accident. Hospital systems optimize for throughput, not understanding. Patients move through beds based on cost, not readiness. Discharge planning becomes a financial decision wrapped in clinical language. A stay under 48 hours can shift the insurance burden dramatically, leaving patients exposed to higher out of pocket costs. Shlomit left the system and built Patient Path NYC, a private patient advocacy service. She now spends 15 to 20 hours a week per client reading charts, coordinating care teams, and translating medical decisions into plain language. Her work sits in the uncomfortable space between healthcare policy and lived experience. Families pay out of pocket to understand their own care. Hospitals benefit from the clarity she provides while maintaining the same structural incentives that created the confusion.This conversation tracks the human cost of fragmented care, the economics behind discharge decisions, and the quiet reality that patients who cannot communicate clearly often lose control of their own outcomes.RELATED LINKSShlomit LibertyShlomit Liberty on LinkedInPatient Path NYCBoard Certified Patient AdvocateFEEDBACKLike this episode? Rate and review Out of Patients on your favorite podcast platform. For guest suggestions or sponsorship email podcasts@matthewzachary.comSee Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.
In this episode, we break down the growing world of lab testing, from beginner-friendly options like Function Health and InsideTracker to advanced biological age and longevity testing like the DunedinPACE and TruHealth test. We discuss the pros and cons of conventional lab ranges, AI interpretations, and how to determine which labs are actually worth your time and money depending on your goals. The conversation also dives into the rise of AI in healthcare, exploring both the incredible potential of AI-driven insights and the limitations of relying too heavily on technology without understanding the bigger picture of your health. Throughout the episode, we share our personal lab recommendations, funny real-life stories, and practical advice for implementing health recommendations on your own. We also explore how mindset, belief systems, and nervous system regulation can directly influence physiology and long-term wellness.SHOW NOTES:0:39 Welcome to the podcast!2:51 How often to run labs5:11 Function Health6:41 Benefits of conventional ranges9:06 Hims & Hers10:16 Blokes & Joi11:08 Which lab to do if you're just getting started 13:59 Positive ANA tests14:40 Inside Tracker16:05 Lauren's lab recommendations17:38 Pros & Cons of AI Health23:53 Lauren's bathroom story25:15 Renee's lab recommendations26:01 Biological Age Testing27:53 DunedIn Pace Test30:06 TruHealth Test31:10 Leptin resistance33:11 *APOLLO NEURO*35:25 Function Health supplements37:03 Recap & our recommendations38:30 How narratives & belief systems affect your physiology41:29 How to implement recommendations on your own49:10 Thanks for tuning in!RESOURCES:Apollo Neuro - Discount code: BIOHACKERBABESFunction Health - code: PSTJEPMGInside Tracker - code: BIOHACKERBABESBlokes & Joi Support this podcast at — https://redcircle.com/biohacker-babes-podcast/donationsAdvertising Inquiries: https://redcircle.com/brands
In 2020, developmental biologist Dr. Crystal Rogers drove the country roads outside Davis, California crying between grant rejections, wondering whether she was about to lose her lab, her career, and the scientific future she had spent years building. She had already done what academia tells young scientists to do. She earned the credentials. She landed a faculty position at UC Davis. She built a lab. Then the real test began.On this episode of Standard Deviation, Dr. Oliver Bogler examines the unspoken rules that determine which scientists survive academic research and which quietly disappear from it. The conversation follows Crystal Rogers and cancer biologist Dr. Michelle Mendoza as they collide with the “Hidden Curriculum” of biomedical science: the unwritten rhetoric, institutional signaling, and grant writing strategies that often decide who receives funding, tenure, and long term stability.Michelle Mendoza entered a tenure track position at the Huntsman Cancer Institute while raising 3 children, navigating a divorce, and trying to secure major NIH funding during COVID. What looked like objective scientific review turned out to depend heavily on persuasion, presentation, and insider fluency. Established researchers could promise massive research agendas based on reputation alone. Junior investigators faced a completely different standard.Oliver traces how the Life Science Editors Foundation and its JEDI program intervened by pairing scientists with former editors from journals including Cell and Nature. The work had little to do with commas or grammar. Editors challenged logic, structure, and scientific framing before grant reviewers could destroy an application in public.Both researchers eventually secured career defining grants. One realized she would keep her job and not have to move her family. The other celebrated by ordering a personalized “DEV BIO” license plate and driving through Davis blasting nineties hip hop and Beyoncé.The episode exposes how biomedical research funding rewards institutional fluency as much as scientific talent, and how hidden systems inside academic medicine continue shaping who gets to stay in science long enough to make discoveries.RELATED LINKSDr. Crystal Rogers LinkedInDr. Crystal Rogers Faculty PageDr. Crystal Rogers LabDr. Michelle Mendoza LinkedInDr. Michelle Mendoza Faculty PageHuntsman Cancer Institute Mendoza LabLife Science Editors FoundationFEEDBACKLike this episode? Rate and review Out of Patients on your favorite podcast platform. For guest suggestions or sponsorship email podcasts@matthewzachary.comSee Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.
What if we could measure mental health as precisely as we measure blood pressure or cholesterol?In this episode, Dr. Jeff Armstrong sits down with Nawal Roy, founder and CEO of Holmusk, to explore how data and technology are transforming the way we understand brain health.With over 970 million people worldwide affected by mental and behavioral health conditions, the current system still relies heavily on trial and error. Nawal and his team are working to change that—building one of the world's largest real-world evidence platforms to bring objective measurement, predictive insight, and personalization to mental healthcare. Together, we explore the future of brain health as a measurable, trackable component of longevity—and what it means for prevention, performance, and aging well.Learn more at https://www.nawalroy.com/https://www.neuroblu.ai/Please, support The Aging Well Podcast by hitting the ‘like' button, subscribing/following the podcast, sharing with a friend, and….Tip Jar! All donations support this podcast to keep it going. https://paypal.me/theagingwellpodcastBUY the products you need to… age well from our trusted affiliates and support the mission of The Aging Well Podcast*.The Aging Well Podcast merchandise | Show how you are aging well | Use the promo code AGING WELL for free shipping on orders over $75 | https://theagingwellpodcast-shop.fourthwall.com/promo/AGINGWELLAuro Wellness | Glutaryl—Antioxidant spray that delivers high doses of glutathione (“Master Antioxidant”) and the new Copper Tripeptide (GHK-Cu) | 10% off Code: AGINGWELL at https://aurowellness.com/agingwellpodcastNutritional Biochemical Inc. (NBI) | Trusted supplement. NBI stands 100% behind the quality of their formulations and the science on which they're based. | Click the following link and use the discount code AGINGWELL for 10% off: https://shop.nbihealth.com/agingwellJigsaw Health | Trusted supplements. “It's fun to feel good.” | Click the following link and use the discount code AGINGWELL for 10% off: https://bit.ly/4ks3Y0OBerkeley Life | Optimize nitric oxide levels | Purchase your starter kit at a 15% discount | Use the promo code: AGINGWELL15 | https://berkeleylife.pxf.io/c/6475525/3226696/31118Oxford Healthspan | Primeadine®, a plant-derived spermidine supplement | 10% off code: AGINGWELL | https://www.oxfordhealthspan.com/AGINGWELLKneeMo | A smart device programmed to reduce your knee pain and keep you moving. | Click the following link and use the discount code AGINGWELL15 for 15% off: https://thekneemo.com/ref/agingwellProlon | The Fasting Mimicking Diet (FMD) is a revolutionary five-day nutrition program scientifically formulated to mimic the effects of a prolonged water fast while still allowing nourishment - supporting the benefits of fasting without the challenges and risks that come from water-only fasts. | For the best available discount always use this link: https://prolonlife.com/theagingwellpodcastL-Nutra Health | The medical division of L-Nutra, focused on helping people manage and potentially reverse chronic health conditions, like type 2 diabetes, prediabetes, insulin resistance, and obesity, using personalized, lifestyle-based programs grounded in evidence, not prescriptions. | Use this link: https://l-nutrahealth.com/theagingwellpodcastThrive25 | Your personal longevity advisor | https://www.thrive25.com/early-access?via=william-jeffreyFusionary Formulas | Combining Ayurvedic wisdom with Western science for optimal health support. | 15% off Code: AGINGWELL | https://fusionaryformulas.com?sca_ref=9678325.IHg5xYhdOzzke8ZrDr Lewis Nutrition | Fight neurodegeneration and cognitive decline with Daily Brain Care by Dr Lewis Nutrition—a proven daily formula designed to protect and restore brain function. | 10% off code: AGINGWELL or use the link: https://drlewisnutrition.com/AGINGWELL*We receive commission on these purchases. Thank you.
In 2008, Katy Talento walked away from Capitol Hill and into a Catholic convent. Within a year, she walked out. Within another decade, she sat inside the White House shaping health policy. Somewhere in between, she got labeled “infertile” after a single cycle of testing and spent years believing it.That label stuck. The pain that came before it never got investigated. Doctors offered birth control and moved on. No one asked why her body was struggling. No one followed the thread.Talento built her career inside the very systems she now critiques. She worked on federal health policy, global disease programs, and later advised the Trump administration on healthcare reform. She helped advance price transparency rules in a system where hospitals can still list 457 different prices for the same service.Then she left.Now she builds employer health plans that bypass insurers, PBMs, and traditional networks. Her approach replaces insurance contracts with direct payment, nurse navigators, and cost sharing models that promise simplicity but raise hard questions about risk and protection.This conversation sits in that tension.Talento describes a healthcare system shaped by layered incentives, where insurers, hospitals, and intermediaries profit from complexity. She argues that employers hold the leverage to disrupt it. The host pushes on what happens when patients fall outside those structures, when contracts disappear, and when community based models fail.The episode moves through infertility, misdiagnosis, insurance design, and the mechanics of employer sponsored care. It tracks how policy decisions made in Washington ripple into exam rooms, billing departments, and family lives.It also confronts a harder truth.Even insiders who understand the system can still get caught in it.RELATED LINKSAllBetter HealthKaty TalentoThem Before UsAn Arm and a LegRelentless Health ValueFEEDBACKLike this episode? Rate and review Out of Patients on your favorite podcast platform. For guest suggestions or sponsorship email podcasts@matthewzachary.comSee Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.
In a wooded campground cabin in the early 2000s, 19 year old Ben Unger stood in the doorway and watched 20 naked men form a circle around a crying teenager. A counselor held up two tangerines and shouted, “These are your balls.” The exercise claimed to cure same sex attraction by forcing young men to “reclaim” their masculinity from overbearing mothers. Phones had been confiscated. Parents had paid thousands of dollars. Religion supplied the script. Pseudoscience supplied the props.Ben had grown up in an Orthodox Jewish community in Brooklyn and later studied in Israel to become a rabbi. When he admitted he felt attracted to men, rabbis told him to eat 7 figs a day, immerse in a ritual bath 5 times daily, or marry a woman and trust that “if there's friction, it works.” At 19, he entered conversion therapy through an organization called Jews Offering New Alternatives to Homosexuality, known as JONAH. He left with depression, religious trauma, and 6 months of silence toward the mother he had been taught to blame.Years later, represented by the Southern Poverty Law Center, Ben helped sue JONAH for consumer fraud in a landmark New Jersey case. The argument centered on evidence, not theology. Sexual orientation cannot be changed. The jury deliberated for 3 hours and ruled against the organization. The verdict helped reshape how states regulate conversion therapy and protect minors from psychological harm disguised as treatment.Today, Ben runs Buff Personal Training in New York City, a gym built on autonomy, mental health, and self respect. His story traces the arc from institutional control to self authorship. The conversation examines religion, LGBTQ rights, conversion therapy, consumer protection law, and the lasting cost of being told your identity is a disorder.RELATED LINKSBen Unger on LinkedInBen Unger on InstagramBUF Personal TrainingSouthern Poverty Law CenterJONAHFEEDBACKLike this episode? Rate and review Out of Patients on your favorite podcast platform. For guest suggestions or sponsorship email podcasts@matthewzachary.comSee Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.
Drew Flugstad-Clarke never planned to work in brain cancer. She planned to play Division I soccer at Georgetown. She planned to paint. She even tried investment banking, answering emails at 4am in a cubicle that never slept. Then in June 2022 her father, Jim, was diagnosed with glioblastoma at 57. He died 1 day shy of 7 months later, just before his 58th birthday. His symptoms began with emotion, not seizures. A steady HR executive suddenly cried. His golf game slipped. By the time he entered the hospital for a scan, he did not leave without surgery. A subway poster for a 5K became a lifeline. Drew showed up. She found a community. She later joined the American Brain Tumor Association as Community Manager for the Eastern Region. This conversation walks through anticipatory grief, caregiving in real time, strategic numbness, and what it costs to curate hope when the median survival clock is already ticking.RELATED LINKSDrew Clark Flukestad on LinkedInTopor StudiosAmerican Brain Tumor AssociationGeorgetown University Women's SoccerFEEDBACKLike this episode? Rate and review Out of Patients on your favorite podcast platform. For guest suggestions or sponsorship email podcasts@matthewzachary.comSee Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.
In this episode, host Sandy Vance sits down with Patricia Thaine, co-founder and chair of Limina (formerly known as Private AI), for a fascinating conversation about one of the most underappreciated bottlenecks in healthcare AI adoption: the privacy of unstructured data. With a background in natural language processing and privacy research, Patricia built the company from the ground up to solve a problem most organizations did not even know they had. Today, her platform helps health systems, research organizations, and payers de-identify everything from clinical notes to ambient listening data so they can train models, share data for research, and move their AI initiatives forward without putting patient privacy at risk. If your AI initiative is stalled because of privacy concerns, this episode is exactly what you need to hear. In this episode, they talk about: 80 to 90% of healthcare data is unstructured, and most organizations have no idea what sensitive information is hiding in it Cloud providers require you to send your data outside your environment, and that alone is a dealbreaker for many health systems De-identification is not just about removing names; quasi-identifiers like age ranges, locations, and diagnoses all factor into re-identification risk The goal is to keep re-identification risk below 0.04%, not just strip out obvious fields Training AI models on real PHI creates a memorization problem where the model can regurgitate patient information in production Providence Health has used Limina since the early days to train patient and physician-facing chatbots safely A mature privacy-to-AI operating model requires statisticians, product teams, IT, governance, and legal all at the table LIMINA rebranded from Private AI because the old name kept attracting requests for on-premise LLMs, which is not what they do A Little About Patricia: Patricia Thaine is the Co-Founder & Chairwoman of Private AI, a Microsoft-backed startup that raised their Series A led by the BDC. Private AI won the Privacy Innovation Award at PICCASO 2024, was named a 2023 Technology Pioneer by the World Economic Forum, and was a Gartner Cool Vendor. Patricia is also the host of The Data Frontier podcast and was on Maclean's magazine Power List 2024 for being one of the top 100 Canadians shaping the country.
Welcome to Mastering Cyber with Host Alissa (Dr Jay) Abdullah, PhD, SVP & Deputy CSO at Mastercard, and former White House technology executive. Listen to this weekly one-minute podcast to help you maneuver cybersecurity industry tips, terms, and topics. Buckle up, your 60 seconds of cyber starts now! Sponsored by Mastercard: https://mastercard.us/en-us.html
Janine Durso spent 30 years inside pharmaceutical advertising shaping healthcare narratives before becoming a belief strategist and founder of The Believist. In November 2024, during a routine Zoom coaching session, she felt what she called a sharp, terrible pain in the right side of her head. Within hours she was in surgery for a ruptured brain aneurysm. She does not remember the ambulance, the ICU, or the first weeks that followed. She spent 5 weeks in intensive care, then 10 days relearning how to walk, calculate simple change, and manage basic cognition. Doctors later placed a stent and continue monitoring a second unruptured aneurysm.This episode traces the moment she told her husband something broke in my brain, the 14 days doctors called touch and go, and the slow mental rebuild that followed. It also examines insurance barriers that require 2 direct relatives with aneurysms before screening coverage, and why she now lobbies in Washington for change.RELATED LINKSJanine DursoThe BelievistBrain Aneurysm FoundationWhite Plains HospitalDr. Jared CooperFEEDBACKLike this episode? Rate and review Out of Patients on your favorite podcast platform. For guest suggestions or sponsorship email podcasts@matthewzachary.comSee Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.
House Democrats are calling on the Trump administration to scrap its plans to collect health data about federal workers from insurance companies. The lawmakers argue that the sensitive information could be used to target employees seeking care it disagrees with. Signers of the letter, which was led by House Oversight ranking member Robert Garcia of California, were specifically concerned about the potential targeting of federal employees who have accessed abortion care, contraceptives, in vitro fertilization (IVF), gender-affirming care, pre-exposure prophylaxis (PrEP) for the prevention of HIV, or any other health care services targeted by Republicans.” The Federal Trade Commission is poised to deepen its involvement in curbing the use of AI for malicious purposes, including the spread of nonconsensual sexualized deepfakes and voice cloning scams. Last year, Congress passed the Take It Down Act, a law that allowed for criminal prosecution of individuals who share or distribute nonconsensual, intimate images and digital forgeries, including those that are AI-generated. Also in this episode: Salesforce Public Sector Strategist Mia Jordan joins host Wyatt Kash in a discussion about how the emerging “agentic enterprise” model could help government eliminate fragmented workflows and operate more efficiently. This segment was sponsored by Salesforce. The Daily Scoop Podcast is available every Monday-Friday afternoon. If you want to hear more of the latest from Washington, subscribe to The Daily Scoop Podcast on Apple Podcasts, Soundcloud, Spotify and YouTube.
Rebecca Benghiat holds a JD, passed the bar, and skipped corporate law to build mental health systems instead. She now serves as Chief of Staff and Head of Impact at Inner Foundation, where she helps direct capital toward emerging adults ages 18 to 30 and asks a hard question every day: Is this actually working?In this conversation, she dismantles the myth of easy fixes. She explains why mental health measurement resists clean metrics, why a PHQ 9 score starts a conversation but never finishes one, and why “scale” often flatters institutions more than it helps people. She breaks down how impact investing shapes care delivery, why schools need networked systems not slogans, and why friction might be developmentally necessary.The stakes are real. Vulnerable families navigate snake oil, glossy apps, and pay to play algorithms while carrying the burden of choice in crisis. Benghiat lives inside that complexity and refuses to simplify it.RELATED LINKSRebecca BenghiatInner FoundationAspen Ideas HealthThe Jed FoundationFEEDBACKLike this episode? Rate and review Out of Patients on your favorite podcast platform. For guest suggestions or sponsorship email podcasts@matthewzachary.comSee Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.
At age 12, Dr. Chrystal Starbird stood by a pond after turning her mother in to the police. She watched tadpoles and fish move beneath the surface and found a strange kind of order. Science became her refuge long before it became her career. Years later, she built that refuge into a profession. She now serves as an Assistant Professor at the University of North Carolina, studies structural biology tied to cancer and Alzheimer's disease, and won Cell's first Rising Black Scientist Award in 2020. On paper, she fits the model of success. In practice, she had to fight for basic access at every stage.Conference travel required upfront cash she did not have. Networking favored pedigree over merit. Mentorship often depended on who knew your name in the room. Chrystal learned those rules, then chose to break them open for others.Oliver Bogler examines what Chrystal calls the advocacy tax. She has delivered over 70 invited talks. Nearly 40 percent focus on equity, mentorship, and policy. Academic reward systems do not count that labor toward tenure. She still does it.Through her leadership at the Life Science Editors Foundation, Chrystal helped build the JEDI program, which pairs underrepresented scientists with editors from journals like Cell and Nature. The program has supported over 100 awardees with more than 1,000 hours of mentorship. This episode exposes how biomedical science rewards output while ignoring the work required to make the system accessible. It also shows what happens when the people most affected refuse to step back.RELATED LINKSDr. Chrystal StarbirdStarbird LabLife Science Editors FoundationJEDI ProgramFEEDBACKLike this episode? Rate and review Out of Patients on your favorite podcast platform. For guest suggestions or sponsorship email podcasts@matthewzachary.comSee Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.
Discover how WHOOP is building an AI-powered health data infrastructure that is redefining how we understand human health. Emily Capodilupo, Senior Vice President of Research, Algorithms, and Data at WHOOP, explains how continuous physiological data is uncovering new opportunities in predictive health through AI, from presymptomatic disease detection to biological age scoring. She examines the governance challenges of deploying AI in a regulated environment and what it takes to build the data trust required to make it work at scale. Key Moments: How WHOOP Built Its AI and Data Foundation (00:57): Emily explains how WHOOP's early focus on elite athlete performance shaped the data collection rigor and multidisciplinary science organization that now powers its predictive health capabilities. She outlines the model she built across AI, machine learning, clinical research, and digital signal processing, and why starting with the highest-demand use case created a data foundation built to scale. The Power of Continuous Data (06:21): Emily draws on WHOOP's sleep research to show how continuous physiological data reveals patterns that would be invisible without longitudinal tracking. She shares findings linking sleep architecture to metabolic disease, cancer risk, and cognitive decline, illustrating why the depth and continuity of a data set determine what insights are actually possible. The Data Governance Challenge of Acting on Sensitive Data (13:17): Emily shares how WHOOP's respiratory rate data could detect COVID infection up to three days before symptom onset in over 80% of cases, but a denied FDA application left the company holding actionable insights it was legally prohibited from sharing. She examines the governance tension that emerges when your data capabilities move faster than the regulatory frameworks designed to govern them. Turning Complex Multi-Signal Data Into a Single Actionable Metric (27:32): Emily introduces WHOOP's Healthspan feature, which translates physiological and behavioral data across nine components into a single biological age score tied to all-cause mortality risk. She explains why distilling complex data into one number is more motivating than presenting raw risk statistics, pointing to research that shows how age-based framing drives stronger behavior change. Building Data Trust and Privacy Infrastructure at Scale (31:40): As WHOOP moves into FDA-cleared products and more sensitive data collection, Emily outlines the governance principles that underpin member trust. She argues that for any organization building on sensitive personal data, the asymmetry between earning trust and losing it should be a foundational design constraint. Key Quotes: "It takes 13 years to earn the trust and one mistake to lose it. And that kind of asymmetry is constantly top of mind." - Emily Capodilupo "We were able to show that we could detect COVID up to three days before symptom onset in over 80% of cases." - Emily Capodilupo “ WHOOP has been collecting data [for] over 12 years. We're working on a lot of new types of algorithms that are able to help people understand their bodies in ways that we might not have appreciated…even just a couple years ago.” - Emily Capodilupo "One of the ways that AI has advanced the product... is this ability to chat with WHOOP in natural language, the way you might chat to a doctor or a trainer or a coach." - Emily Capodilupo Mentions Harvard Study | Analyzing changes in respiratory rate to predict the risk of COVID-19 infection Cornell Study Uses WHOOP Sleep Data to Monitor Patients at Risk for Alzheimer's Can Data Help Us Sleep Better? | WHOOP There's More to Sleep than Sleep Need: The Importance of Sleep Consistency | WHOOP Cribsheet & Expecting Better 2 Books Collection Set By Emily Oster The Family Firm: A Data-Driven Guide to Better Decision Making in the Early School Years By Emily Oster Guest Bio Emily Capodilupo is an award-winning AI and research leader with more than 13 years of experience building and scaling science-driven organizations in fast-paced startup environments. She began her career as an emergency medical technician before studying neurobiology and human sleep at Harvard University and conducting research at Brigham and Women's Hospital. Emily is driven by a passion for using data to solve hard problems and advance our understanding of human physiology. Along the way, she "accidentally" became a data scientist, recognizing that the biggest breakthroughs in health require not just rigorous science, but big data and bold technology. As WHOOP's first employee, Emily founded and now leads the company's science organization, pioneering a new model of health that begins long before diagnosable illness and is continuous, personalized, AI-powered, and designed to empower individuals to take the driver's seat in their own well-being. She has built and scaled multidisciplinary teams across artificial intelligence, machine learning, digital signal processing, clinical research, and engineering to translate real-time physiological data into actionable insights that improve performance, resilience, and long-term health. Emily's work sits at the intersection of wearable technology, digital biomarkers, and predictive health, helping shift healthcare from reactive treatment to proactive optimization. Hear more from Cindi Howson here. Sponsored by ThoughtSpot.
At 19, Jansher Naim went from sharp stomach pain to a Stage 4 fibrolamellar diagnosis that few doctors see and even fewer young adults survive. He pushed through 41 rounds of chemotherapy, a Whipple surgery, and months of isolation while his friends kept moving through normal college life. In the studio, Jansher sits beside his mother Sadia Siddiqui, who refused early defeat and helped overhaul his care team when the first plan offered little optimism. Now a Computer Science student at Columbia, Jansher lives in the uneasy space between remission and risk, managing fertility decisions, travel for ongoing care, and the strange pressure to look fine at 22. Together they describe what it takes to grow up fast inside a system that rarely knows what to do with young adults who refuse to disappear.RELATED LINKSJansher NaimSadia SiddiquiFibroFighters FoundationColumbia UniversityFEEDBACKLike this episode? Rate and review Out of Patients on your favorite podcast platform. For guest suggestions or sponsorship email podcasts@matthewzachary.comSee Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.
Jessica Federer built her career inside the rooms where science, money, and power collide. As the first female Chief Digital Officer at Bayer, she helped steer a 120,000 person global company through the rise of digital medicine while confronting a harder truth: women were excluded from U.S. clinical trials until 1993. In this conversation, she explains how decades of “first in man” research shaped drug development, why women experience side effects at nearly 2x the rate of men, and how guidance on sex based differences did not arrive from the FDA until December 2025. She shares what it means to sit on a Yale Institutional Review Board, why clinical trial stipends over $3,000 get taxed, and why she believes participants deserve tax credits instead. From GLP 1 profits to $40,000,000 women's health funds that barely move the needle, this episode names the gaps and the opportunity hiding inside them. RELATED LINKSJessica Federer on LinkedInJessica Federer on InstagramYale School of Public HealthHealth of Women Investor SummitFEEDBACKLike this episode? Rate and review Out of Patients on your favorite podcast platform. For guest suggestions or sponsorship email podcasts@matthewzachary.comSee Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.
Monique Gore Massey spent 2.5 years cycling through New York City emergency rooms while her body shut down. Fevers hit 105. Her weight dropped from 122 pounds to 72 in 3 months. Hair fell out in clumps. No one ran an ANA test. Doctors blamed stress, old sports injuries, migraines. When a physician finally named it lupus, she added that she hoped it was not. Months later, Monique heard the words “get your affairs in order.”In this episode, Monique details living with lupus nephritis, pericarditis, fibromyalgia, and the daily math of survival. She recounts arriving at a patient conference shortly after coming off crutches and requesting elevator access for support, only to face resistance at a health summit that claimed to center patients. She breaks down what it costs when industry extracts lived experience for free and calls it engagement. Listeners will hear what invisible illness looks like in real time, how bias delays diagnosis, and why advocacy without strategy leaves patients exploited instead of respected.RELATED LINKSMonique Gore MasseyLupus Foundation of AmericaFEEDBACKLike this episode? Rate and review Out of Patients on your favorite podcast platform. For guest suggestions or sponsorship email podcasts@matthewzachary.comSee Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.
Teresa Baglietto has lived through the kind of compounded harm that exposes how thin the safety net really is. In this episode she walks through a life shaped by medical neglect, personal violence, and the exhausting labor of self advocacy. She nearly died after a C section when hospital staff failed to confirm she had urinated before discharge, spending 15 days hospitalized and separated from her newborn while facing the possibility of permanent damage. In 2013 she discovered an aggressive breast cancer and waited weeks for test results and surgery while administrators stalled and passed responsibility. Care only moved forward after she threatened public exposure. Teresa also speaks openly about surviving rape in high school, losing her father to cancer at age 48 when she was 10, and growing up without reliable adults in the room. She explains why it took 7 years to write her book, why she launched a podcast, and how sales grit becomes a survival tool when patients must fight systems designed to delay them. The conversation stays specific, unsentimental, and grounded in consequence.RELATED LINKSTeresa Baglietto on LinkedInThe Ripple Effect by Teresa BagliettoIn Shock PodcastIn Shock Podcast on InstagramCanvas Rebel interview with Teresa BagliettoFEEDBACKLike this episode? Rate and review Out of Patients on your favorite podcast platform. For guest suggestions or sponsorship email podcasts@matthewzachary.comSee Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.
Science likes to call itself a meritocracy. Angela Anderson and Brandi Mattson know better. Both served as editors at elite journals (Cell and Neuron), where a single decision could determine who gets tenure, funding, or obscurity. They watched brilliant data get filtered out because the authors did not know the unwritten rules controlled by 5 dominant publishing houses with profit margins higher than Google.In 2020, amid pandemic shutdowns and national reckoning over racial injustice, they co-founded a nonprofit to expose that hidden curriculum. Through the JEDI program, they provide 10 hours of free editorial consulting to scientists who lack access to elite networks. In 1 year alone, 25 awards helped researchers salvage canceled grants, secure NSF career funding, and rebuild careers derailed by rejection.This episode pulls back the curtain on the multibillion dollar publishing engine that profits from taxpayer funded science and reveals who gets heard, who gets sidelined, and how insiders are choosing to redistribute power.RELATED LINKSAngela AndersonBrandy MattsonLife Science EditorsLife Science Editors FoundationCellNeuronNational Science FoundationFEEDBACKLike this episode? Rate and review Out of Patients on your favorite podcast platform. For guest suggestions or sponsorship email podcasts@matthewzachary.comSee Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.
Today's episode of Out of Patients welcomes Dr Pamela Buchanan, an emergency room physician with over 20 years inside American medicine who refuses to sugarcoat what the job demands and what it destroys. She worked straight through COVID as protocols changed by the day and deaths arrived faster than anyone could process. She logged 80 to 100 hour weeks. She isolated from her family to avoid bringing the virus home. Over time, survival began to feel negotiable.Dr Buchanan speaks openly about burnout as emotional flatline and about physician suicide as a predictable outcome that leadership prefers to ignore. She describes the ER as the catch all for a broken system and explains why chronic care collapses there by design. She shares the reality of trying to access mental health care while still practicing medicine, calling dozens of therapists, getting nowhere, and spending $10,000 to $15,000 out of pocket just to stay alive and functional.Listeners will hear how neurodivergence shaped her career in emergency medicine, how race and trust intersect inside hospital walls, and why doctors are leaving in waves. This conversation carries clarity, anger, humor, and hard earned truth from someone who stayed long enough to name the damage.RELATED LINKSDr Pamela BuchananStrong MedicineDr Pamela Buchanan on LinkedInDr Pamela Buchanan on InstagramEmotional Flatline articleKevinMD essay by Dr Pamela BuchananFEEDBACKLike this episode? Rate and review Out of Patients on your favorite podcast platform. For guest suggestions or sponsorship email podcasts@matthewzachary.comSee Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.
Dr. Barbara Paldus is the Founder and CEO of CODEX Labs, the sponsor of this episode.She grew up around Nobel Prize winners, built biotech manufacturing equipment for vaccines and cancer therapeutics, and then sold her company after an 8 year old threatened suicide.Her son's severe eczema pushed her into an unregulated $100,000,000,000 skincare market where parents are told to trust labels that nobody verifies. She explains how corticosteroid ladders leave patients with years long withdrawal, why U.S. ingredient oversight lags Europe, and how chemotherapy destroys the same skin and gut barriers seen in inflammatory disease.The conversation tracks the real stakes behind “clean” marketing: a child's immune system, hospital infections like MRSA, and patients trying to survive treatment without new damage. She also details the research path from Irish medical manuscripts to microbiome science and why sick populations become the only reliable regulators when policy fails.RELATED LINKSBarbara PaldusCodex LabsSekhmet VenturesDr Peter LioFEEDBACKLike this episode? Rate and review Out of Patients on your favorite podcast platform. For guest suggestions or sponsorship email podcasts@matthewzachary.comSee Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.
Dr Eugene Manley grew up in Detroit in the 1980s cycling through emergency rooms 20 to 30 times a year with asthma and anaphylaxis while hospital staff talked past his family and buried them in paperwork they could not decode. He responded by earning a BS in mechanical engineering an MS in biomedical engineering and a PhD in molecular biology cell biology and biochemistry. Along the way he tore his ACL training for a jiu jitsu black belt worked 86 straight days in a lab during his doctorate and learned how academic and clinical systems punish people who refuse to shrink.In this episode Manley walks through a recent post surgery ordeal at Mount Sinai Queens where staff falsified records attempted an illegal discharge and nearly sent him home on the wrong blood thinner. He explains how medical racism shows up in charts staffing and decision making and why measurable equity fails without accountability. Listeners hear how his STEMM and Cancer Health Equity Foundation builds pipelines for underrepresented students challenges clinical trial design and teaches patients how to protect themselves when institutions lie. RELATED LINKS• Eugene Manley Jr• STEMM and Cancer Health Equity Foundation• Village Voice• LUNGevity FoundationFEEDBACKLike this episode? Rate and review Out of Patients on your favorite podcast platform. For guest suggestions or sponsorship email podcasts@matthewzachary.comSee Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.
In this episode, Freddie and Renee zoom out on the modern wellness landscape—where tech, supplements, scans, and strong opinions are everywhere—and make a case for discernment over dogma. They talk candidly about online criticism, influencer skepticism, and why “trying things” only works when you introduce tools one at a time, track outcomes (HRV, sleep, glucose), and don't confuse information with wisdom. The through-line is simple: foundational health still matters, but intelligent experimentation can be powerful when it's paired with humility and real feedback loops. Then the conversation goes deep into two high-stakes areas people rarely discuss honestly: full-body MRI screening and biological dentistry. Renee shares her Prunuvo experience—how a possible kidney finding triggered weeks of stress and a cascade of follow-up imaging and specialist visits, raising the hard question of where early detection ends and false positives begin. From there, she opens up about a long dental arc that started with a traumatic accident at 16, eventually leading her to remove older titanium implants, manage bone loss and grafting, and transition to zirconia ceramic implants—not as fear-based medicine, but as a “reduce the burden” choice while she explores chronic fatigue, immune markers, and Episode Highlights [00:00] – Renee's Pranuvo full-body MRI experience and the 15mm kidney stone scare [16:02] – False positives, medical rabbit holes, and the emotional/financial cost of early detection [22:53] – Top health yardsticks: glucose markers, HRV, sleep tracking, and foundational labs [25:08] – CGMs, cortisol testing (Dutch & ELi Health), and why trends matter more than single data points [27:15] – Genetic testing, APOE4 status, and using DNA as a focus tool (DNA Company & SelfDecode) [51:37] – Renee's dental trauma story: accident, titanium implants, and root canal decisions [54:56] – Titanium implants, ANA positivity, chronic fatigue, and biocompatibility concerns [59:22] – Surgery recovery protocol: red light therapy, StemRegen, BPC-157 & TB-500 peptides [01:29:10] – Closing reflections and exosome therapy mention Links & Resources Learn more about Renee Belz → https://reneebelz.com/ Follow Renee on Instagram → https://www.instagram.com/reneebelz/ Listen to the Biohacker Babes: https://podcasts.apple.com/us/podcast/renee-belz-lauren-sambataro/id1470189843 Get Silver Biotics: bit.ly/3JnxyDD — 30% off with Code: BEAUTIFULLYBROKEN Try CatchBio: https://catchbio.com — Code: BEAUTIFULLYBROKEN LightPathLED: https://lightpathled.pxf.io/c/3438432/2059835/25794 — Code: beautifullybroken StemRegen: stemregen.co/products/stemregen?_ef_transaction_id=&oid=1&affid=52 — Code: beautifullybroken CONNECT WITH FREDDIEWork with Me: https://www.beautifullybroken.world/biological-blueprintWebsite and Store: (http://www.beautifullybroken.world) Instagram: (https://www.instagram.com/freddie.kimmelYouTube: https://www.youtube.com/@beautifullybrokenworld Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.
© 2020-2026 Ivy Podcast Discovery LLC
